6 Steps to Better Imaging for Transgender Patients
Radiologists can play an active role in improving the healthcare experience for transgender patients, most of whom have had a negative imaging encounter.
Across the United States, 1.4 million individuals identify as being transgender. Although that accounts for only 0.6 percent of adults, these individuals frequently need imaging services, particularly if they opt to pursue gender affirmation surgery, referred to as transitioning.
Unfortunately, recently published research revealed that 71 percent of transgender patients have experienced at least one negative encounter with an imaging provider. There is currently a lack of information about data-driven practices that can improve the care these patients receive, so a multi-institutional team, led by Hannah Perry, M.D., a diagnostic radiologist with the University of Vermont Medical Center, published six steps in the Journal of the American College of Radiology to help radiologists provide the best care possible to this group.
Take a quick look at their recommendations:
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-newsletter here.
FDA Clears Enhanced MRI-Guided Laser Ablation System
June 5th 2025An alternative to an open neurosurgical approach, the Visualase V2 MRI-Guided Laser Ablation System reportedly utilizes laser interstitial thermal therapy (LITT) for targeted soft tissue ablation in patients with brain tumors and focal epilepsy.
Can Abbreviated MRI Have an Impact in Differentiating Intraductal Papilloma and Ductal Secretion?
June 3rd 2025For patients with inconclusive ultrasound results, abbreviated breast MRI offers comparable detection of intraductal papilloma as a full breast MRI protocol at significantly reduced times for scan acquisition and interpretation, according to a new study.
FDA Issues Expanded Pediatric Approval of MRI Contrast Agent for Lung Ventilation Assessment
June 2nd 2025Previously approved for MRI lung ventilation evaluation in adults and children 12 and older, the hyperpolarized contrast agent Xenoview can now be utilized for pediatric patients six years and older.
